查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1608213

無引線心臟心律調節器市場：按產品、最終用戶分類 - 2025-2030 年全球預測

Leadless Cardiac Pacemaker Market by Product (Micra Transcatheter Pacing System, Nanostim Leadless Pacemaker), End-User (Academic & Research Institutes, Ambulatory Surgical Centers, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，無引線心臟心律調節器市值為2.7717億美元，預計到2024年將達到2.9439億美元，複合年成長率為7.83%，預計到2030年將達到4.7001億美元。

無引線心臟心律調節器是心臟技術的重要進步，旨在為心搏過緩患者提供不需要電線或手術袋的起搏治療。該設備使傳統心律調節器小型化，降低感染風險並提高患者舒適度。其需要強調的是能夠維持心率而不出現與經靜脈導線系統相關的併發症。最終用戶主要包括醫院和循環系統診所，適用於各種患者群體的心搏過緩治療。無引線心臟心律調節器市場的成長是由心血管疾病盛行率上升、對微創手術的需求增加以及穿戴式醫療技術的技術進步等因素所推動的。機會存在於開拓的市場，在這些市場中，傳統心律調節器仍然廣泛使用，新興國家的醫療設施正在升級。市場相關人員正在專注於與醫療保健提供者的夥伴關係，擴大研發力度，以進一步縮小設備尺寸，同時延長電池壽命，並提高成本效益以提高採用率。然而，市場面臨著高昂的設備成本、嚴格的監管核准流程以及來自先進藥物干預和新興生物電子學等替代療法的潛在競爭的挑戰。其他限制包括目前無法提供雙腔室起搏，這可能會限制其在某些患者群體中的使用。創新領域包括用於遠端監控的物聯網整合、更長的設備壽命以及針對更複雜的心臟疾病的擴展適應症。這個市場的本質是快節奏，高度依賴不斷的技術創新，要求相關公司保持敏捷、具有前瞻性，並利用新興技術來保持競爭力。

主要市場統計
基準年[2023] 27717萬美元
預計年份 [2024] 2.9439億美元
預測年份 [2030] 47001萬美元
複合年成長率（%） 7.83%

市場動態：揭示快速發展的無引線心臟心律調節器市場的關鍵市場洞察

無引線心臟心律調節器市場正在因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 心臟病盛行率上升
    • 心律調節器優惠報銷措施
    • 擴大覆蓋範圍以減少術後併發症和感染疾病
  • 市場限制因素
    • 心律調節器的技術限制
  • 市場機會
    • 無引線心臟心律調節器的技術進步
    • 增加門診手術中心的投資
  • 市場問題
    • 嚴格的政府措施和缺乏熟練的專家

波特五力：駕馭無引線心臟心律調節器市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解無引線心臟心律調節器市場的外部影響

外部宏觀環境因素在塑造無引線心臟心律調節器市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解無引線心臟心律調節器市場的競爭格局

對無引線心臟心律調節器市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣：無引線心臟心律調節器市場供應商的績效評估

FPNV定位矩陣是評估無引線心臟心律調節器市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製無引線心臟心律調節器市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，無引線心臟心律調節器市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心臟病發病率上升
      • 心律調節器優惠報銷措施
      • 擴大覆蓋範圍以減少術後併發症和感染疾病
    • 抑制因素
      • 心律調節器的技術限制
    • 機會
      • 無引線心臟心律調節器的技術進步
      • 加大門診手術中心建設投入
    • 任務
      • 嚴格的政府政策和缺乏熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章無引線心臟心律調節器市場：依產品

  • 介紹
  • Micra 經導管心律調節系統
  • Nano Stim 無導線心律調節器

第7章無引線心臟心律調節器市場：依最終用戶分類

  • 介紹
  • 學術研究所
  • 門診手術中心
  • 醫院

第8章美洲無引線心臟心律調節器市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太無引線心臟心律調節器市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的無引線心臟心律調節器市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cairdac
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic PLC
  • Vitatron Holding BV
Product Code: MRR-2E42D71A28F7

The Leadless Cardiac Pacemaker Market was valued at USD 277.17 million in 2023, expected to reach USD 294.39 million in 2024, and is projected to grow at a CAGR of 7.83%, to USD 470.01 million by 2030.

Leadless cardiac pacemakers represent a significant advancement in cardiac technology, designed to provide pacing therapy to patients with bradycardia without the need for wires or a surgical pocket. This device miniaturizes traditional pacemakers, reducing infection risks, and improving patient comfort. Their necessity is underscored by their ability to maintain heart rate without the complications associated with transvenous lead systems. End-users primarily include hospitals and cardiology clinics, with applications spanning bradycardia treatment across various patient demographics. The market growth for leadless cardiac pacemakers is driven by factors such as the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and technological advancements in wearable health tech. Opportunities lie in untapped markets where traditional pacemakers are still prevalent and developing nations are upgrading their medical facilities. Market players are advised to focus on partnerships with healthcare providers, expanding R&D activities to reduce device size further while enhancing battery life, and improving cost-effectiveness to enhance adoption rates. The market is, however, challenged by high device costs, stringent regulatory approval processes, and potential competition from alternative therapies like advanced pharmaceutical interventions or emerging bioelectronics. Limitations also include the current inability to provide dual-chamber pacing, which can limit their use in certain patient populations. Innovative areas ripe for exploration include integrating IoT for remote monitoring, enhancing device longevity, and expanding indications for use in more complex cardiac conditions, which will further cement their role in futuristic cardiovascular care. The nature of this market is fast-paced and heavily reliant on constant innovation, necessitating that companies involved are agile and forward-thinking, leveraging emerging technologies to maintain a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 277.17 million
Estimated Year [2024] USD 294.39 million
Forecast Year [2030] USD 470.01 million
CAGR (%) 7.83%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Leadless Cardiac Pacemaker Market

The Leadless Cardiac Pacemaker Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cardiac disorders
    • Favorable reimbursement policies for pacemakers
    • Increasing applicability to reduce postoperative complications and infections
  • Market Restraints
    • Technical limitations of pacemakers
  • Market Opportunities
    • Technological advancements in leadless cardiac pacemaker
    • Growing investments for advancement of ambulatory surgical centers
  • Market Challenges
    • Stringent governmental policies and scarcity of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Leadless Cardiac Pacemaker Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Leadless Cardiac Pacemaker Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Leadless Cardiac Pacemaker Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Leadless Cardiac Pacemaker Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Leadless Cardiac Pacemaker Market

A detailed market share analysis in the Leadless Cardiac Pacemaker Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Leadless Cardiac Pacemaker Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Leadless Cardiac Pacemaker Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Leadless Cardiac Pacemaker Market

A strategic analysis of the Leadless Cardiac Pacemaker Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Leadless Cardiac Pacemaker Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Boston Scientific Corporation, Cairdac, Lepu Medical Technology(Beijing)Co., Ltd., Medtronic PLC, and Vitatron Holding B.V..

Market Segmentation & Coverage

This research report categorizes the Leadless Cardiac Pacemaker Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Micra Transcatheter Pacing System and Nanostim Leadless Pacemaker.
  • Based on End-User, market is studied across Academic & Research Institutes, Ambulatory Surgical Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cardiac disorders
      • 5.1.1.2. Favorable reimbursement policies for pacemakers
      • 5.1.1.3. Increasing applicability to reduce postoperative complications and infections
    • 5.1.2. Restraints
      • 5.1.2.1. Technical limitations of pacemakers
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in leadless cardiac pacemaker
      • 5.1.3.2. Growing investments for advancement of ambulatory surgical centers
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent governmental policies and scarcity of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Leadless Cardiac Pacemaker Market, by Product

  • 6.1. Introduction
  • 6.2. Micra Transcatheter Pacing System
  • 6.3. Nanostim Leadless Pacemaker

7. Leadless Cardiac Pacemaker Market, by End-User

  • 7.1. Introduction
  • 7.2. Academic & Research Institutes
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Hospitals

8. Americas Leadless Cardiac Pacemaker Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Leadless Cardiac Pacemaker Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Leadless Cardiac Pacemaker Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Boston Scientific Corporation
  • 3. Cairdac
  • 4. Lepu Medical Technology(Beijing)Co., Ltd.
  • 5. Medtronic PLC
  • 6. Vitatron Holding B.V.

LIST OF FIGURES

  • FIGURE 1. LEADLESS CARDIAC PACEMAKER MARKET RESEARCH PROCESS
  • FIGURE 2. LEADLESS CARDIAC PACEMAKER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. LEADLESS CARDIAC PACEMAKER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. LEADLESS CARDIAC PACEMAKER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LEADLESS CARDIAC PACEMAKER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LEADLESS CARDIAC PACEMAKER MARKET DYNAMICS
  • TABLE 7. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY MICRA TRANSCATHETER PACING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY NANOSTIM LEADLESS PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. LEADLESS CARDIAC PACEMAKER MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. LEADLESS CARDIAC PACEMAKER MARKET, FPNV POSITIONING MATRIX, 2023